SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

	March 31, 2020		December 31, 2019
	($ in thousands)
Cash and cash equivalents	$	8,094	$	25,813
Restricted cash and cash equivalents	735,954		742,093
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows	$	744,048	$	767,906

Restrictions on Cash and Cash Equivalents

	March 31, 2020		December 31, 2019
	($ in thousands)
Cash and cash equivalents	$	8,094	$	25,813
Restricted cash and cash equivalents	735,954		742,093
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows	$	744,048	$	767,906

Financing Receivable, Allowance for Credit Loss

The following table provides a roll-forward of the Company’s allowance for credit losses on notes receivable:

	Three months ended March 31
	2020			2019
	($ in thousands)
Balance at beginning of period	$	15,000		$	9,012
Cumulative effect of adoption of ASU 2016-13 at January 1, 2020	750			—
Charge offs	(15,000		)	—
Net increase (decrease) in allowance	250			—
Balance at end of period	$	1,000		$	9,012

Schedule of Interest Income and Interest Expense

For the three months ended March 31, 2020 and 2019, the interest income/(expense) on deposit accounted contracts was as follows:

	Three months ended March 31
	2020		2019
	($ in thousands)
Deposit interest income	$	607	$	1,048
Deposit interest expense	$	—	$	(48	)
Deposit interest income/(expense), net	$	607	$	1,000

Schedule of Weighted Average Number of Shares

The table below presents the shares outstanding for the purposes of the calculation of earnings (loss) per share for the three months ended March 31, 2020 and 2019:

	Three months ended March 31
	2020	2019
Weighted average shares outstanding - basic	36,138,245	35,972,665
Effect of dilutive employee and director share-based awards	—	391,693
Weighted average shares outstanding - diluted	36,138,245	36,364,358
Anti-dilutive stock options outstanding	875,627	935,627
Participating securities excluded from calculation of loss per share	1,326,613	—